Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06230692 · ClinicalTrials.gov registry record · NA

Diaphragm Structure and Function in Children

A NA study of Respiratory Muscle Training, sponsored by University of Maryland, Baltimore.

Recruiting
Registry status
NA
Development phase
13
Enrollment target
1
Study location

NCT06230692: Recruiting NA study of Respiratory Muscle Training, sponsored by University of Maryland, Baltimore.

NCT06230692 is a NA study of Respiratory Muscle Training that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06230692, a NA study of Respiratory Muscle Training, is actively recruiting participants, sponsored by University of Maryland, Baltimore.

RECRUITING
Registry status
NA
Development phase
13 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to study the feasibility of a specific training program for the breathing muscles (inspiratory muscle training) and the effects on how breathing is regulated during exercise in typically developing children.

Primary Outcome

Percentage of enrolled participants who complete the 6-week inspiratory muscle training protocol

Interventions

  • DEVICE POWERbreathe Plus IMT

Study Locations (1)

Maryland

  • University of Maryland, Baltimore - Baltimore

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2024-03-16
Est. Completion 2025-12
Phase NA
University of Maryland, Baltimore

560 total trials

What NCT06230692 shows while recruiting

NCT06230692 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Respiratory Muscle Training appearing as the primary indexed condition, and to 1 intervention - of which POWERbreathe Plus IMT is the first listed.

NCT06230692 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT06230692 about?

NCT06230692 is a clinical study titled "Diaphragm Structure and Function in Children". The purpose of this research is to study the feasibility of a specific training program for the breathing muscles (inspiratory muscle training) and the effects on how breathing is regulated during exercise in typically developing children.

What is the current status of trial NCT06230692?

This trial is currently recruiting. It is a NA study. The enrollment target is 13 participants. The study started on 2024-03-16. Estimated completion is 2025-12.

What conditions does trial NCT06230692 study?

This clinical trial studies the following conditions: Respiratory Muscle Training.

What interventions are being tested in trial NCT06230692?

The interventions under investigation include: POWERbreathe Plus IMT (DEVICE).

Who is sponsoring clinical trial NCT06230692?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06230692 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT06230692's enrollment target sits among peer trials

13 1911th of 2000 higher than 88 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06230692, the US trial registry maintained by the National Library of Medicine. NCT06230692 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.